BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Saeedi-Boroujeni A, Mahmoudian-Sani MR, Nashibi R, Houshmandfar S, Tahmaseby Gandomkari S, Khodadadi A. Tranilast: a potential anti-Inflammatory and NLRP3 inflammasome inhibitor drug for COVID-19. Immunopharmacol Immunotoxicol 2021;43:247-58. [PMID: 34015982 DOI: 10.1080/08923973.2021.1925293] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 11.0] [Reference Citation Analysis]
Number Citing Articles
1 Cao J, Gong Y, Wu M, Xiong L, Chen S, Huang H, Zhou X, Peng Y, Shen X, Qu J, Wang Y, Zhang X. Molecular docking and molecular dynamics study Lianhua Qingwen granules (LHQW) treats COVID-19 by inhibiting inflammatory response and regulating cell survival. Front Cell Infect Microbiol 2022;12. [DOI: 10.3389/fcimb.2022.1044770] [Reference Citation Analysis]
2 Dagher D, Elmansi H, Nasr JJ, El-Enany N. Utility of a novel turn-off fluorescence probe for the determination of tranilast, an adjunctive drug for patients with severe COVID-19. RSC Adv 2022;12:22044-53. [PMID: 36043110 DOI: 10.1039/d2ra02239g] [Reference Citation Analysis]
3 Palma G, Sorice GP, Genchi VA, Giordano F, Caccioppoli C, D’oria R, Marrano N, Biondi G, Giorgino F, Perrini S. Adipose Tissue Inflammation and Pulmonary Dysfunction in Obesity. IJMS 2022;23:7349. [DOI: 10.3390/ijms23137349] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Ferrari D, Rubini M, Burns JS. The Potential of Purinergic Signaling to Thwart Viruses Including SARS-CoV-2. Front Immunol 2022;13:904419. [DOI: 10.3389/fimmu.2022.904419] [Reference Citation Analysis]
5 Jia H, Qi X, Fu L, Wu H, Shang J, Qu M, Yang C, Wang J. NLRP3 inflammasome inhibitor ameliorates ischemic stroke by reprogramming the phenotype of microglia/macrophage in a murine model of distal middle cerebral artery occlusion. Neuropathology. [DOI: 10.1111/neup.12802] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Saeedi-boroujeni A, Nashibi R, Ghadiri AA, Nakajima M, Salmanzadeh S, Mahmoudian-sani M, Hanafi MG, Sharhani A, Khodadadi A. Tranilast as an Adjunctive Therapy in Hospitalized Patients with Severe COVID- 19: A Randomized Controlled Trial. Archives of Medical Research 2022. [DOI: 10.1016/j.arcmed.2022.03.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
7 Alkattan W, Yaqinuddin A, Shafqat A, Kashir J. NET-Mediated Pathogenesis of COVID-19: The Role of NETs in Hepatic Manifestations. Journal of Health and Allied Sciences NU. [DOI: 10.1055/s-0041-1741418] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Mallick U. Treatment Options in CoViD19. Cardiovascular Complications of COVID-19 2022. [DOI: 10.1007/978-3-030-90065-6_5] [Reference Citation Analysis]
9 Zafar-mohammadi K, Poursamimi J, Atabaki M. NLRP3 inflammasome activation and its inhibitory drugs in connection with COVID-19 infection. Eur J Inflamm 2022;20:1721727X2211309. [DOI: 10.1177/1721727x221130984] [Reference Citation Analysis]
10 Amin S, Aktar S, Rahman MM, Hassan Chowdhury MM. NLRP3 inflammasome activation in COVID-19: an interlink between risk factors and disease severity. Microbes Infect 2021;:104913. [PMID: 34838941 DOI: 10.1016/j.micinf.2021.104913] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
11 Mahnam K, Ghobadi Z. Finding a prospective dual-target drug for the treatment of coronavirus disease by theoretical study. J Biomol Struct Dyn 2021;:1-21. [PMID: 34514953 DOI: 10.1080/07391102.2021.1973910] [Reference Citation Analysis]
12 Farouk AF, Shafqat A, Shafqat S, Kashir J, Alkattan K, Yaqinuddin A; College of Medicine, Alfaisal University, Riyadh, Saudi Arabia, Medical College, Aga Khan University, Karachi, Pakistan, Department of Comparative Medicine, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia. . AIMSMOLES 2021;8:275-90. [DOI: 10.3934/molsci.2021021] [Reference Citation Analysis]